Stefan Ries

Stefan Ries has extensive experience in the pharmaceutical industry, with a strong background in oncology research and development. Currently serving as the Chief Scientific Officer at DISCO Pharmaceuticals GmbH, Stefan has previously held key positions at Versant Ventures and Roche, where Stefan played significant roles in external innovation, oncology, and biologics research. With a PhD in Biochemistry from the University of Regensburg, Stefan's career highlights include leading innovative projects in cancer immunotherapy, molecular targeted therapies, and oncolytic viruses.